Jim Cramer
Wynn is nearly again in Macao and crushing it in Vegas even in advance of Tremendous Bowl, Chinese New 12 months
Wynn Resorts posted beats on its best and base lines in the fourth quarter. In outcomes unveiled immediately after the closing bell Wednesday, both of those Macao places and Las Vegas have been powerful although Boston Harbor was in essence in line with expectations. The Club stock moved larger in just after-hrs investing. Working revenue […]
Read More
Wall Street gives 2 of our healthcare stocks well-deserved price target bumps
Wall Street liked what it saw from GE Healthcare and Eli Lilly in their earnings reports, leading to a round of well-deserved price target bumps for the Club stocks. Analysts at four equity research firms boosted their price targets for GE Healthcare since the maker of MRI machines and other medical equipment on Tuesday delivered […]
Read More
GEHC stock finally gets some respect after earnings. Those betting against it got slammed
Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns about China. That coupled with management’s upbeat view of this year propelled shares up more than 13% to over $83 each at session highs. That was their highest level since July 2023. The Club stock closed just under $82. Total […]
Read More
Wall Street says Big Tech needs to take a breather after huge run. Here's our take
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks were mixed Tuesday, on a muted performance from Big Tech. Citigroup strategists warned that tech stocks may stall out after monstrous gains. “The large consensus positioning is […]
Read More
Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday
Clorox – The consumer products giant saw a huge earnings beat. It’s also rebounding from last year’s cyberattack. “Things are back online, and there’s tremendous demand for their product,” Jim said Friday’s Morning Meeting rapid fire. Tesla – The EV leader issued a recall for 2.2 million cars over a warning light issue. Remember, our […]
Read More
January was great for stocks — here are our top 5 performers for the month
Benchmark gauges notched all-time highs as stocks charged through a busy earnings season. Source
Read More
We're trimming a health-care stock ahead of earnings — hedging our bets on business in China
We’re selling 95 shares of GE Healthcare at roughly $74. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 1,150 shares of GEHC, reducing its weighting to 2.75% from 2.97%. The small trim we’re making in GE Healthcare with the stock up slightly in an otherwise rough tape does not change our belief in this […]
Read More
CrowdStrike CEO talks Microsoft's security breach and describes why Russian hackers are really hard to beat
In a Monday interview with CNBC’s Jim Cramer, CrowdStrike CEO George Kurtz talked about Microsoft‘s significant-profile protection breach by a Russian intelligence team, indicating these adversaries have a decided “lower and gradual” strategy to hacking that’s particularly challenging to conquer. Microsoft introduced on Friday that the team, regarded as Nobelium, carried out the attack and […]
Read More
Why we like health-care stocks in 2024 despite their spotty record in presidential election years
As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical convention. The S & P 500 Health Care Sector […]
Read More
4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry
Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured so much of the growth as Abbott Labs , […]
Read More